Antibodies to watch in 2022-Reference-Cited by-同舟云学术

Antibodies to watch in 2022

Published:2022-01-14 Issue:1 Volume:14 Page:
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Kaplon Hélène¹^ORCID,Chenoweth Alicia²^ORCID,Crescioli Silvia²^ORCID,Reichert Janice M.³^ORCID

Affiliation:

1. Translational Medicine Department, Institut de Recherches Internationales Servier, Suresnes, France

2. St. John’s Institute of Dermatology, School of Basic & Medical Biosciences, King’s College London, London, UK

3. The Antibody Society, Inc, Framingham, MA, USA

Funder

reported

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/19420862.2021.2014296

Reference178 articles.

1. Antibodies to watch in 2010

2. FDA approves 100th monoclonal antibody product

3. Centers for Disease Control and Prevention. SARS-CoV-2Variant classifications and definitions. [Updated 2021 Oct 4 [accessed 2021 Nov 1]. www.cdc.gov/coronavirus/2019-ncov/variants/variant-info.html.

4. U.S. Food and Drug Administration. Emergency use authorization. [Updated 2021 Oct 29 accessed 2021 Nov 1]. www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization.

Cited by 280 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging trends and therapeutic applications of monoclonal antibodies;Gene;2024-10

2. In silico mediated workflow for rapid development of downstream processing: Orthogonal product-related impurity removal for a Fc-containing therapeutic;Journal of Chromatography A;2024-10

3. Development of Uniform Ribosome Display Technology Enabling Easy and Efficient Identification of Full‐Length Proteins that Interact with Bioactive Small and Large Molecules;ChemBioChem;2024-09-12

4. Facile Rebridging Conjugation Approach to Attain Monoclonal Antibody-Targeted Nanoparticles with Enhanced Antigen Binding and Payload Delivery;Bioconjugate Chemistry;2024-09-10

5. Food and Drug Administration (FDA) Approvals of Biological Drugs in 2023;Biomedicines;2024-09-02